Groupe Hospitalier Pellegrin Tripode

Bordeaux 33075

1 studies enrolling now · 3 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Metastatic Urothelial Carcinoma, Prostate Cancer, Unresectable Urothelial Carcinoma

Studies at this site

• Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients — Recruiting now
• Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205) — Stopped early
• A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease — Stopped early